PATA: FG must provide support, enabling environment for HIV vaccine research

 

May 18 is observed as HIV Vaccine Awareness Day globally. As we join the international community to mark this day in Nigeria Positive Action for Treatment Access (PATA), recognizes and thank all the volunteers, community members, health professionals, civil society advocates and scientists involved in HIV vaccine research

This day also presents a unique opportunity to educate communities about the importance of HIV vaccine research.

No doubt there has been much progress in HIV/AIDS research globally. Antiretroviral therapies have contributed to longer and healthier lives for people living with HIV. Pre- exposure prophylaxis has helped to reduce the risk of HIV infection by those not living with HIV.

While these and other preventive tools have the power to reduce the incidence of HIV infection, a safe and effective vaccine would even yield better outcomes. A vaccine would drastically reduce the number of people who become infected and contribute immensely to the global target of ending the AIDS epidemic by 2030.

As effort towards HIV vaccine intensifies in Nigeria, attention should be given to the following:

  • Government at all levels (local, state and federal), should put in place adequate structures and enabling environment to promote vaccine research and development.
  •  Intensive training and retraining of local personnel especially scientists and researchers and exposure to global best practices.
  • Continue on going prevention efforts to reduce new infections, and intensify treatment, care and support services for those infected, while keeping the search for vaccine in focus.
  • Aggressively promote local content in the search for vaccine. The  resolution at the 4th National Council recently held in Abuja, March 19-20, 2018 (Resolution 6:Council approved that the local manufacture of Anti-retroviral (ARV) drugs, Rapid Test Kits (RTKs) and other HIV-related commodities be encouraged (NCA/04/19B) is indeed the way to go with the vaccine initiative in Nigeria.
  • Need for intensive partnership between funders, scientists, advocates and community stakeholders.
  • Community engagement should be given top priority at all stages of the vaccine research and development process.
  • Ensuring ethical standards in trials to ensure we have a vaccine that is “safe, effective, durable, affordable, and accessible.”
  • Mobilization of resources to ensure that the vaccine, when available, gets to the people who need it.
  • Active engagement of people living with HIV and civil society advocates in the research and development process.
  • Massive sensitization as a strategy to address issues of stigma and discrimination. Partnership with the media for effective awareness creation is most desirable.

Keep up with NHVMAS activities on our social media platforms and join the conversation

Facebook: www.facebook.com/nhvmas

Twitter: @nhv_mas

HVAD: NIMR urges Nigerians to support HIV vaccine research

HVAD: NIMR urges Nigerians to support HIV vaccine research

HVAD: NIMR urges Nigerians to support HIV vaccine research

THE NIGERIA INSTITUTE OF MEDICAL RESEARCH INVESTED IN DEVELOPMENT OF A HIV VACCINE RESPONSIVE TO THE CIRCULATING HIV STRAIN IN NIGERIA

Image result for salako NIMR

On the 18th of    May,    2018 HIV vaccine advocates in many countries around the globe will be commemorating the HIV Vaccine Awareness Day. The concept of Global HIV Vaccine Awareness Day emerged from the May 18, 1997 inauguration speech made by then-President William Jefferson Clinton at Morgan State University. He challenged the world to set new goals in the emerging age of science and technology and develop a HIV vaccine within the next decade. Since then, the advocates and communities around the world has commemorated this day with activities to raise awareness about HIV vaccine.

Today, the Nigerian Institute of Medical Research Lagos happily joins the global community to celebrate the almost four decades of investment of researchers, research volunteers, community members, health professionals, funders in developing a HIV vaccine. Tremendous progress has been made and we remain hopeful a HIV vaccine will be developed.

We join HIV vaccine advocates to urge the international community to continue to recognize the importance of investing in new technologies as a critical element of a comprehensive response to the HIV and AIDS epidemic. We further call on Nigeria and Nigerians to recognize, support and invest not only in HIV vaccine research but research in general.

The race to developing a HIV vaccine is a marathon race. Slow and steady but assuredly that the end will be sooner than later. It requires investment, hard work, and the non-stop commitment towards a goal. The race requires countries around the world to invest in research that makes it feasible for its citizens to benefit from the global research.

Nigeria is committed to joining forces to ensure we not only develop a HIV vaccine, but ensure we address barriers and challenges to its access when developed. As always, we shall lead the policy formulation landscape, offer relevant trainings and speak up as advocates for access to the finished product. We are committed to ensuring Nigeria is not left behind in the race to end the HIV and AIDS epidemic.

Researchers in NIMR are aware that the strain of the HIV virus that circulates in Nigeria is quite distinct from other strain circulating elsewhere. It is the least responsive to VRC01. For this reason, the institute is watching the field as it evolves so it acts responsibly for the care of Nigerians.

NIMR Lagos is a house hold name in the fight against HIV epidemic. Since 2002, we have not only provided comprehensive HIV care treatment and support to over 24,000 Nigerians adult, pregnant women and children, but have also set the pace in innovative care delivery. In recent times, we have sought for collaboration with leading HIV research institutions in Africa to improve our research outcomes, including research for a HIV vaccine highly sensitive to the Nigerian HIV strain.

We are committed to providing an enabling environment and opportunities for HIV vaccine research in Nigeria. We look forward to new partnerships and collaborations to advance the global agenda to develop a HIV vaccine accessible to all in the shortest possible time.

 

Professor Babatunde Lawal Salako MD, FWCP, FRCP

Director General

 

Keep up with NHVMAS activities on our social media platforms and join the conversation

Facebook: www.facebook.com/nhvmas

Twitter: @nhv_mas

HVAD: NACA urges collaborative, focused action on HIV vaccine

HVAD: NACA urges collaborative, focused action on HIV vaccine

HVAD: NACA urges collaborative, focused action on HIV vaccine

NACA PRESS STATEMENT

Image result for saliu naca boss

Today marks the 21st anniversary of global efforts to develop a HIV vaccine. Although progress in HIV vaccine development by the scientific community continues to raise hope that one day this feat will be achieved, a lot of work is still required.

The HIV Vaccine Awareness Day is a day that recognizes stakeholders involved in HIV vaccine research, including health professionals, volunteers, members of the civil society and scientists. It provides an opportunity to educate communities about the importance of developing a HIV vaccine for both preventive and treatment purposes.

Over 3 million people in Nigeria are living with HIV. Every new infection has social and economic consequences for the country. A successful HIV vaccine would reduce the number of new infections and also slow the progress of the illness in those infected with the virus. It is important for all stakeholders to double their efforts to ensure that Nigeria as a country contributes positively to the development of a HIV vaccine.

The Director General of the National Agency for the Control of AIDS (NACA), Dr Sani Aliyu, is optimistic that developing a HIV vaccine is feasible in the not-too-distant future, and calls for renewed commitment by all stakeholders to make this feat happen. ‘’ As we mark World HIV Vaccine Day, I call for a renewed commitment from all stakeholders to push for the realization of the production of this much needed vaccine’’

The established roadmap for HIV vaccine development is vigorously being followed, with stakeholders conducting operational and implementation research to address potential barriers that can hinder access to HIV Vaccines. NACA, in partnership with the New HIV Vaccine and Microbicide Advocacy Society (NHVMAS) will continue to collaborate with relevant stakeholders in promoting community education and awareness as well as intensify efforts to ensure that an effective HIV vaccine is developed to arrest the HIV epidemic at a global level.

Keep up with NHVMAS activities on our social media platforms and join the conversation

Facebook: www.facebook.com/nhvmas

Twitter: @nhv_mas

Accelerating the era of HIV vaccination by Linda-Gail Bekker

Accelerating the era of HIV vaccination by Linda-Gail Bekker

Accelerating the era of HIV vaccination by Linda-Gail Bekker

By Linda-Gail Bekker, International AIDS Society President

Vaccines are modern miracles. Every year, vaccines save up to 3 million lives worldwide [[1]]. The measles vaccine alone has saved more than 20 million lives since 2000 [[2]]. Smallpox, a disease that as recently as the 1960s was associated with a death toll comparable to HIV, has now been eradicated as a result of vaccination efforts. Immunization programmes are on the cusp of eliminating polio, and expanded use of the hepatitis B vaccine is contributing to reductions in the global burden of that disease as well [[3]].

In the case of HIV, no preventive vaccine is currently available. But we have come a very long way in the search for an HIV vaccine, with a rich research and development pipeline that now includes an array of approaches to HIV immunization.

My own involvement in HIV vaccine research began in 2004 when we did the first community-based “willingness to participate” studies. Gratifyingly, we discovered that communities in South Africa believe in vaccines and have great hope for an effective HIV vaccine. Although the earliest vaccine research did not yield an effective vaccine, these efforts left us with lessons and insights that have proven invaluable in the search for an effective vaccine.

Indeed, there are signs that we might soon see a light at the end of the tunnel. In 2009, a clinical trial in Thailand confirmed for the first time that a vaccine could prevent HIV infection. Currently, I am serving as Co-Chair of HVTN 072 together with Dr Glenda Grey (Chair); this is a large efficacy trial in South Africa of a vaccine that is evaluating what we hope is an improved version of the vaccine tested in the Thai trial. One of my sites is also involved in one of a series of studies evaluating whether intravenous infusions of HIV antibodies can protect against HIV acquisition.

In my many years of HIV vaccine research, I’ve learned a lot about what makes a successful vaccine trial. In particular, community engagement and support is an essential building block for successful research. In South Africa, communities are thirsting for an HIV vaccine and are ready to put to use a vaccine proven to be safe and effective. Given the grassroots enthusiasm for new methods to prevent HIV infection, people are eager to enrol in vaccine research in South Africa. And communities have actively stepped forward to promote and support these HIV prevention trials.

The worst possible outcome for a large, expensive Phase III efficacy trial is a set of results that are ambiguous, unclear or difficult to interpret. That’s why such care and thought goes into the design and roll out of a Phase III trial. The past several years have seen an exciting expansion of HIV prevention options, but this has paradoxically made vaccine trials more difficult to design. Our studies offer all participants access to PrEP – an ethical imperative, but one that complicates efforts to compare the experimental vaccine arm of the trial with a control group. This means that innovation in the design of new trials will be critical as we move forward in our search for an effective HIV vaccine.

For those of us who have witnessed the highs and lows of our quest for a preventive vaccine, these are exciting times. But we aren’t there yet, and there is a real risk that long-term commitment to finding a vaccine could wither over time. We must not allow that to happen, as a preventive vaccine will likely be essential for ending the HIV epidemic once and for all.

It is our hope that through the recently announced partnership between the International AIDS Society (IAS) and the Global HIV Vaccine Enterprise, we will foster new collaborations between the HIV vaccine community and the broader HIV community to work towards our common goal of accelerating the era of HIV vaccination.

Not that long ago, many leading scientific experts questioned whether a vaccine against HIV was even feasible. We now know that the potential for HIV vaccination is real. We must now redouble our efforts and be smart in our choices, so that we reach the ultimate finish line in our fight against HIV.

1http://www.who.int/en/news-room/fact-sheets/detail/immunization-coverage.

https://www.cdc.gov/mmwr/volumes/65/wr/mm6544a6.htm.

https://www.thelancet.com/journals/langas/article/PIIS2468-1253(18)30056-6/fulltext

Keep up with NHVMAS activities on our social media platforms and join the conversation

Facebook: www.facebook.com/nhvmas

Twitter: @nhv_mas

Imagine a world free from HIV…

Imagine a world free from HIV

I once had the privilege of working in an HIV testing/counseling center. Prior to that time, I only had a limited overview of what this disease was and how much people were affected. From time to time, I would visit the phlebotomy laboratory where blood collection was done to carry out CD4 tests and viral load and I would see a long queue of people. I started to get curious because I didn’t want to believe that the number of HIV patients was so much on the rise.

One good day, it was my turn to be in the blood collection table and it was so hectic. There was no breathing space as we had a large pool of patients both for rapid tests and cd4 count. In the midst of my busy day, I saw a woman walk in with a baby strapped at her back and another 2 year old. All through my days in that laboratory, I had not seen a baby or a two-year old child tested positive. It broke me to even find out that the mother was not taking all the necessary measures to take care of those children and even herself. I had tears in my eyes as I imagined a world where these children could be free from HIV.

HIV is a major public health problem around the world and the need for an HIV vaccine cannot be overemphasized. It would not only save this generation but it would keep generations to come from seeing the horrible sight of a child that could be spared of HIV infection if only there was a permanent way out like a vaccine.

HIV management has made commendable progress since the identification of the disease: awareness and prevention programs, development of anti-retroviral drugs to contain the effect of the infect, funding and aids channeled towards helping the larger population of developing countries to manage this disease. It is time we kick this disease out finally.

Imagine a world where about 36 million people currently infected with HIV would be able to live life and be free. A world where allocation of funds towards HIV projects would be diverted towards other social and economic development projects. A world where a mother will not have to live in regret for infecting her child with a permanent virus. A world where love partners wouldn’t have to go their separate ways just because one partner is infected. A world where there wouldn’t be a need for stigmatization.

Imagine a WORLD FREE FROM HIV.

The World needs HIV vaccine

The World needs HIV vaccine

The World needs HIV vaccine
Inline image
 

By Chinye Osa-Afiana

The hype on HIV has been ongoing for several years, and it’s no surprise that the need for a vaccine is gaining same popularity.

It would be so easy to give a long essay on the need and importance of this vaccine, but personally, I have questions to ask my teenage self. As a teen, would I readily take the HIV vaccine if it was made available? I honestly doubt it.

First of all, I’m very sure my mum would say a huge NO!! This could mean a license to engage in illicit sex. Also, there’s the fear of needles and the concern on the frequency of the vaccine intake. But then, this is just me.

It’s easy to take solace in ignorance and absolve oneself from taking responsibility of certain life-altering issues. This is seen in our attitude towards going the extra mile to think of solutions to long standing issues, we most times do not care as long as we are not directly affected. But then, as it concerns HIV, the devastating trail of bodies it has left in its wake as the years go by has prompted the outcry for investments into finding a lasting solution to this menace.

One can only imagine how far this pursuit to a lasting solution has come, as there are still many getting infected and dying from HIV infection.

Google was kind enough to provide this concise info.

But then, all hope is not lost. Yes. There is hope; concerned individuals, institutions and various governments are partnering up to provide a lasting end to this menace in the form of a vaccine.

The question now is; how have you contributed to the end of the spread of the virus? How have you tried to increase your knowledge about the search for the vaccine? How have you helped a friend, neighbor or stranger to be more aware on the work done to finding a cure to AIDS? Above all, will you readily let go of myths & cultural beliefs to receive a HIV vaccine, if made available?

Like in the case of small pox and polio, this vaccine can also give back confidence to all affected directly or indirectly by the disease.

My good friend google to the rescue!!!

It is no longer a thought, or an imagination, or a far-fetched idea of an idealist. It is real. And it is happening now. Join the crusade in increasing the awareness for HIV vaccine in your community. A little word here, a little word there, will eventually go viral, causing the appropriate persons to take heed of our concerns. I personally, will no longer live under the shackles of myths and cultural beliefs concerning vaccines.

I choose to break free of these unseen chains. I choose to be guided by accurate information. And I choose to make informed decisions that will impact positively on members of my community.

The world needs a vaccine. Africa needs a vaccine. Nigeria needs the vaccine.

How can you contribute???